Welcome to the UK and Éire Glaucoma Society website.
UK and Éire Glaucoma Society
UK and Éire Glaucoma Society (UKEGS) is a non-profit national scientific society, and part of Glaucoma UK, which aims to:
- Establish personal contacts and to promote the exchange of knowledge between glaucoma specialists and those involved in the management and care of glaucoma patients in the UK and Éire.
- Stimulate glaucoma research by bringing together scientists and clinicians involved in glaucoma research, thereby establishing a scientific community with similar interests/aims and building a sense of comradeship and active co-operation.
- Promote an interest in glaucoma as a sub-speciality in trainee ophthalmologists and those in related occupations.
- Keep contact with other glaucoma societies within and outside the UK & Éire.
- Promote, protect and foster the interests and care of people living with – or at risk of developing glaucoma.
2023 UKEGS Conference information and tickets
UKEGS proudest achievement is its annual conference aimed mainly at the ophthalmology community, but increasingly of interest to optometrists and other professionals. The 2023 conference will be held in London, the hometown of the current President, Professor Gus Gazzard on 22 and 23 November 2023.
Become a UKEGS member
The UKEGS annual conference is an opportunity to network, share the latest research and hear from inspiring speakers
You must be a UKEGS member to attend our annual conference. UKEGS membership is free and means you’ll hear about our conference, research grants and news. You’ll also hear about opportunities to your views on topics like professional practice and standards.
The RCOphth and UKEGS collaboratively developed a clinical tool for classification of patients with glaucoma into strata of risk for significant future sight loss and an estimate of resource requirement for managing the patient. The tool acknowledges diagnosis, stage of disease, complexity of disease, rate of disease progression, life expectancy, ocular and systemic comorbidities, dependency and socio-economic deprivation. The eye-level classification should be used to stratify patients according to the worse eye which has remaining useful vision, for which the patient is willing to undergo treatment to retain sight.
Glaucoma Risk Stratification Tool
UKEGS is overseen by a panel of ophthalmologists, currently:
Prof Pete Shah
UKEGS President 2021
Prof Gus Gazzard
UKEGS President 2022
Prof Anthony King FRCOphth MD
Glaucoma UK Chair and Clinical Advisory Panel
Ms Nishani Amerasinghe